21.20.Z - Manufacture of medicines and other pharmaceutical products
26.70.Z - Manufacture of optical instruments and photographic equipment
28.29.Z - Manufacture of other general-purpose machinery notelsewhere classified
32.50.Z - Manufacture of medical and dental instruments and supplies
46.46.Z - Wholesale of pharmaceutical goods
47.19.Z - Other retail sale in non-specialised stores
47.52.Z - Retail sale of hardware, paints and glass in specialised stores
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.78.Z - Other retail sale of new goods in specialised stores
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
74.10.Z - Specialised design activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60.Z - Educational support activities
86.10.Z - Hospital activities
86.90.E - Other human health activities notelsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | -0 | 0,5 | 2167,6 |
EBITDA | -0 | 0,5 | 3904,9 | |
Short time liabilities | 0,4 | 1 | 159 | |
Income tax | 0 | -∞ | ||
Equity capital | 0,4 | 0,4 | 0,8 | 112,7 |
Operating profit (EBIT) | -0 | 0,5 | 2167,6 | |
Assets | 0,6 | 0,7 | 1,7 | 136,7 |
Net profit (loss) | 0,1 | -0 | 0,4 | 1318 |
Cash | 0,1 | 0,8 | 496,7 | |
Net income from sale | 2,7 | 3,9 | 40,5 | |
Liabilities and provisions for liabilities | 0,2 | 0,4 | 1 | 159 |
Working assets | 0,6 | 0,7 | 1,7 | 142,6 |
Depreciation | 0 | 0 | 29,5 | |
Basic operational activity income | 2,1 | -19,6 | ||
% | % | % | p.p. | |
Profitability of capital | 13,5 | -9,2 | 53 | 62,2 |
Equity capital to total assets | 67,5 | 48,2 | 43,3 | -4,9 |
Gross profit margin | 2,8 | -0,8 | 11,7 | 12,5 |
EBITDA Margin | -0,4 | 12,1 | 12,5 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 51 | 93 | 42 | |
Current financial liquidity indicator | 1.8107044696807861 | 1.695857048034668 | -0,1 | |
Net dept to EBITDA | 7.977128982543945 | -1.5716572999954224 | -9,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane